{
    "nctId": "NCT02871167",
    "briefTitle": "Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation",
    "officialTitle": "Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 140,
    "primaryOutcomeMeasure": "Quality of oocytes: total number of oocytes preserved",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with histologically proven breast cancer\n* Aged 18 to 38 years old\n* Planned adjuvant chemotherapy\n* No prior chemotherapy\n* Affiliated to a public health insurance program\n* Informed consent signed by the patient\n\nExclusion Criteria:\n\n* Metastatic breast cancer\n* Planned neo-adjuvant chemotherapy\n* Hysterectomy\n* Exclusive adjuvant hormonotherapy\n* Positive serology for syphilis, hepatitis B or C, or VIH\n* Contraindication related to use of r-FSH\n* Pregnant or breastfeeding patients",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}